Literature DB >> 27871822

Geroscience: Addressing the mismatch between its exciting research opportunities, its economic imperative and its current funding crisis.

George M Martin1.   

Abstract

There is at present a huge disconnect between levels of funding for basic research on fundamental mechanisms of biological aging and, given demographic projections, the anticipated enormous social and economic impacts of a litany of chronic diseases for which aging is by far the major risk factor: One valuable approach, recently instigated by Felipe Sierra & colleagues at the US National Institute on Aging, is the development of a Geroscience Interest Group among virtually all of the NIH institutes. A complementary approach would be to seek major escalations of private funding. The American Federation for Aging Research, the Paul Glenn Foundation and the Ellison Medical Foundation pioneered efforts by the private sector to provide substantial supplements to public sources of funding. It is time for our community to organize efforts towards the enhancements of such crucial contributions, especially in support of the emerging generation of young investigators, many of whom are leaving our ranks to seek alternative employment. To do so, we must provide potential donors with strong economic, humanitarian and scientific rationales. An initial approach to such efforts is briefly outlined in this manuscript as a basis for wider discussions within our community.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Animal models of Alzheimer's disease; Antigeroid alleles; Comparative gerontology; Developmental biology, intergenerational and transgenerational inheritance; Epigenetic drift; Geroscience; Healthspan/lifespan ratios; Induced pleuripotent stem cells; Pet dogs; Research funding; Stem cell niches; Young plasma, somatic cell genetics

Mesh:

Year:  2016        PMID: 27871822      PMCID: PMC5438291          DOI: 10.1016/j.exger.2016.11.008

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  47 in total

1.  Heterogeneity in healthy aging.

Authors:  David J Lowsky; S Jay Olshansky; Jay Bhattacharya; Dana P Goldman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-11-17       Impact factor: 6.053

2.  Epigenetic gambling and epigenetic drift as an antagonistic pleiotropic mechanism of aging.

Authors:  George M Martin
Journal:  Aging Cell       Date:  2009-09-02       Impact factor: 9.304

Review 3.  Transgenerational epigenetic inheritance in mammals: how good is the evidence?

Authors:  Sanne D van Otterdijk; Karin B Michels
Journal:  FASEB J       Date:  2016-04-01       Impact factor: 5.191

Review 4.  Genetic modulation of senescent phenotypes in Homo sapiens.

Authors:  George M Martin
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

5.  Long-lived species have improved proteostasis compared to phylogenetically-related shorter-lived species.

Authors:  Harrison Pride; Zhen Yu; Bharath Sunchu; Jillian Mochnick; Alexander Coles; Yiqiang Zhang; Rochelle Buffenstein; Peter J Hornsby; Steven N Austad; Viviana I Pérez
Journal:  Biochem Biophys Res Commun       Date:  2015-01-21       Impact factor: 3.575

Review 6.  Aging of the innate immune system.

Authors:  Albert C Shaw; Samit Joshi; Hannah Greenwood; Alexander Panda; Janet M Lord
Journal:  Curr Opin Immunol       Date:  2010-08       Impact factor: 7.486

Review 7.  Articulating the Case for the Longevity Dividend.

Authors:  S Jay Olshansky
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

Review 8.  The central role of muscle stem cells in regenerative failure with aging.

Authors:  Helen M Blau; Benjamin D Cosgrove; Andrew T V Ho
Journal:  Nat Med       Date:  2015-08       Impact factor: 53.440

9.  Prevalence of mixed pathologies in the aging brain.

Authors:  Jasmin Rahimi; Gabor G Kovacs
Journal:  Alzheimers Res Ther       Date:  2014-11-21       Impact factor: 6.982

10.  Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts.

Authors:  Bidisha Saha; Alexander Cypro; George M Martin; Junko Oshima
Journal:  Aging Cell       Date:  2014-02-05       Impact factor: 9.304

View more
  4 in total

Review 1.  Multimorbidity and functional impairment-bidirectional interplay, synergistic effects and common pathways.

Authors:  A Calderón-Larrañaga; D L Vetrano; L Ferrucci; S W Mercer; A Marengoni; G Onder; M Eriksdotter; L Fratiglioni
Journal:  J Intern Med       Date:  2018-11-22       Impact factor: 8.989

Review 2.  Phenotypic Screening in C. elegans as a Tool for the Discovery of New Geroprotective Drugs.

Authors:  Sven Bulterijs; Bart P Braeckman
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-25

3.  Lessons for aging from Werner syndrome epigenetics.

Authors:  George M Martin; Martin Poot; Thomas Haaf
Journal:  Aging (Albany NY)       Date:  2020-02-05       Impact factor: 5.682

Review 4.  Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives.

Authors:  Alexander Vaiserman; Oleh Lushchak
Journal:  J Transl Med       Date:  2017-07-20       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.